Search results for: 'software license revenue m8de'
- Related search terms
- Software-Defined Instruments and Reinvented Business Models to Impact Market Outlook, Communication Test Revenues to Soar
- Software-as-a-Service Value Proposition - A Look Under the Hood
- software as a medical device the new frontier for growth for med tech oems
- revenue estimates for payment fraud prevention services
- revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related test
-
18 Jul 2018  |  Global  |  Market Research
US Medical Marijuana Market, Forecast to 2022
Medical Cannabis Revenue will Overtake Recreational in the Next 4 Years
The medical marijuana market is growing in the United States despite the fact that the Food and Drug Administration (FDA) has not yet approved any medical marijuana products. These marijuana-based products have not yet passed through the rigorous tests and clinical trials required for medical drug approvals in the United States. At the Federal le...
$3,000.00 -
20 Jun 2017  |  North America  |  Market Research
Transformation and Growth Opportunities in the US Next-Generation Sequencing Informatics Market
Pharmaceutical and Molecular Diagnostics Segments to Lead Revenue Growth
Frost & Sullivan expects strong demand for commercial application-focused solutions to drive new investments in the development of tools and technologies, and will also result in consolidation of the US next-generation sequencing informatics market. Changing customer requirements and intense competition will drive the transformation. As companies l...
$4,950.00 -
20 Mar 2019  |  North America  |  Market Research
Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022
Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure
Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...
$4,950.00 -
21 Nov 2014  |  North America  |  Market Research
Analysis of the US LIMS Market
Pharmaceuticals and Biobanks Spur Market Revenue with Increasing Adoption of Thin-client Web-based Systems
The laboratory information management systems (LIMS) market in the United States has been a mature space for many years. The evolution of laboratory needs has spurred innovation in this industry, forcing vendors to change their approach toward consumers. Consumers have the option of choosing between thick-client (Web-enabled) solutions, thin-client...
$3,950.00 -
05 Sep 2024  |  Global  |  Market Research
The Evolving Role of Extended Reality in Healthcare: The Metaverse and Digital Health 4.0
Trends, Challenges, and Transformation in the Healthcare Extended Reality Industry
Extended reality (XR) is an umbrella term that encompasses a broad spectrum of immersive technologies, including mixed reality (MR), augmented reality (AR), and virtual reality (VR) technologies. Regarding healthcare IT, the early-medium stage healthcare XR market is still finding use cases through which it can expand geographically and to other ap...
$2,450.00 -
25 Jun 2019  |  Global  |  Technology Research
Technologies Transforming the Biomanufacturing Landscape
Translating Technology Innovation to Market Competitiveness
Overall Impact of Biomanufacturing Technology Innovations Impact on Unmet Needs Pharmaceutical companies perceive analytical services as important. There is a need for a robust platform that enables the provision of such services. Pharma firms are outsourcing crucial processes and are utilizing services such as analytics, research, process developm...
$4,950.00 -
05 Apr 2023  |  Asia Pacific  |  Market Outlook
Asia-Pacific Pharmaceutical Industry Outlook, 2023
Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry
Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...
$4,950.00 -
28 Jun 2024  |  Global  |  Market Research
Life Science Instrumentation and Research Tools Driving Transformational Growth through Automation Global, 2023 2029
A Steady Increase in Laboratory Budgets in Academia is Driving Innovation
This study analyzes the life science instrumentation and research tools industry, covering the chemicals, consumables, instruments, reagents, suppliers, and IT solutions used in research laboratories. The global market for life science instrumentation and research tools is projected to experience steady growth from 2023 to 2029, achieving significa...
$4,950.00 -
23 Feb 2021  |  North America  |  Market Research
AI-Based Image Analysis Tools and Cloud-Based Deployment to Expand the Global Digital Pathology Market
Increased Demand for Remote Pathology Services and Centralization of Digital Pathology Workflow in Hospital Networks to Spark New Growth Opportunities
The Transformational Health team at Frost & Sullivan provides critical insights into the global digital pathology market, highlighting key growth opportunities, market revenue forecast, and business models that will play an essential role in its growth. The study segments the market by product (hardware, software, and storage solutions) and region ...
$4,950.00 -
14 Mar 2022  |  North America  |  Market Outlook
Next-generation Diagnostics Outlook, 2022
Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth
In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...
$4,950.00